Results 41 to 50 of about 9,327,495 (300)

An unusual unifocal presentation of Castleman’s disease in a young woman with a detailed description of sonographic findings to reduce diagnostic uncertainty: a case report [PDF]

open access: yes, 2013
Background: Castleman’s disease is a rare lymphoproliferative disorder. It typically presents as mediastinal masses and causes a wide range of clinical symptoms.
Maden, Zerrin, Wagner, Norbert
core   +1 more source

Retroperitoneal Castleman’s Disease [PDF]

open access: yesCase Reports in Oncology, 2019
Castleman’s disease was first reported in 1954 by Castleman et al. and identified as an uncommon lymphoproliferative disorder. In most cases, Castleman’s diseases are detected in the chest, head, and neck. A 71-year-old man was referred to our hospital due to a retroperitoneal tumor in the para-aortic area by computed tomography (CT). Positron emission
Kota Shimokihara   +7 more
openaire   +3 more sources

Castleman Disease

open access: yesSurgical Pathology Clinics, 2019
Castleman disease (CD) is divided clinically into unicentric or multicentric type. Pathologically, CD is divided into hyaline-vascular and plasma cell variants. Unicentric CD is most common, about 75% of these cases are hyaline-vascular variant, and surgical excision is often curative.
Wei, Wang, L Jeffrey, Medeiros
openaire   +3 more sources

Benign TdT-positive cells in pediatric and adult lymph nodes: a potential diagnostic pitfall [PDF]

open access: yes, 2018
Benign TdT-positive cells have been documented in a variety of non-hematopoietic tissues. Scant data are however available on their presence in non-neoplastic lymph nodes.
AGOSTINELLI, CLAUDIO   +8 more
core   +1 more source

Castleman′s disease with paraneoplastic pemphigus

open access: yesIndian Journal of Dermatology, 2014
Castleman′s disease is a rare autoimmune disorder with varied clinical presentations. Castleman′s commonly involves mediastinum and hence it is thoracic in most of the reported cases. Paraneoplastic pemphigus (PNP) and myasthenia gravis can be associated
Dinesha   +4 more
doaj   +1 more source

Repurposing Interleukin-6 Inhibitors to Combat COVID-19. [PDF]

open access: yes, 2020
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is a pandemic with major implications across the world. One of the most frequent causes of death from SARS-CoV-2 is fatal pneumonia from coronavirus disease 2019 (COVID-19), which is associated
Kato, Shumei, Kurzrock, Razelle
core   +1 more source

Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease

open access: yesBlood Advances, 2022
Key Points Siltuximab leads to rapid normalization of symptomatology and most abnormal laboratory parameters and prolongs PFS in patients with iMCD.
F. van Rhee   +6 more
semanticscholar   +1 more source

Quantitative analysis of a rare disease network’s international contact database and E-repository provides insights into biobanking in the electronic consent era

open access: yesOrphanet Journal of Rare Diseases, 2019
Background Castleman disease (CD) describes a group of rare and poorly understood lymphoproliferative disorders that include unicentric CD (UCD), Human Herpes Virus-8 (HHV8)-associated multicentric CD (HHV8 + MCD), and HHV8-negative/idiopathic MCD (iMCD).
Alexander Suarez   +2 more
doaj   +1 more source

Multicentric Castleman disease and the evolution of the concept

open access: yesPathologica, 2021
Summary The term multicentric Castleman disease (MCD) encompasses a spectrum of conditions that share some overlapping clinicopathological manifestations.
Ting Zhou   +3 more
semanticscholar   +1 more source

Two cases of Castleman Disease with Nonspecific Clinical Presentations [PDF]

open access: yesInternational Journal of Hematology-Oncology and Stem Cell Research, 2009
Castleman disease (CD) is a rare, lymphoproliferative disorder of uncertain etiology. We are reporting on two cases of Castleman disease. Both patients were female. This disease can be found wherever lymph nodes are present.
Shahrbanou Keyhanian   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy